# Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy

> **NCT00530569** · — · UNKNOWN · sponsor: **Alberta Health services** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Blood Test

## Key facts

- **NCT ID:** NCT00530569
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530569, "Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00530569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*